We are very pleased that we've been able to continue the momentum with our biopharma customer base, including 5 new large pharma logos and 7 new ... related to the Bio Fab 1 facility.

Aspire Biopharma’s (ASBP) contract manufacturer, Glatt Air Techniques, completed its first Good Manufacturing Practice Clinical Batch of its ...

Oppenheimer downgraded Sutro Biopharma (STRO) to Perform from Outperform. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses.

This brings an inflection point in the biopharma sector, by forging a sustainable pathway for the industry to cater to India’s collective aim of a 45% reduction in emission intensity by 2030 and ...

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today ...

SAN FRANCISCO - GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company with a market capitalization of $4.63 million, has announced the withdrawal of its Registration ...

GC Biopharma announced on the 14th that it received approval from the Ministry of Food and Drug Safety for the clinical trial plan (IND) for an adult combined vaccine against tetanus, diphtheria ...

Lead asset CR-001, a tetravalent PD-1 x VEGF bispecific antibody, on track for IND filing in the fourth quarter of 2025 Novel ADCs CR-002 and CR-003 on track for development as single agents and ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative ...

With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...